StockIQpro
NASDAQ:JAGX

Jaguar Health, Inc.

Track all markets on TradingView
Track all markets on TradingView

Jaguar Health, Inc.'s revenue fell 1.5% in fiscal 2025 to $11.5M while operating margin fell to −398.8%. The diluted share count rose 691.9%.Summary generated from Jaguar Health, Inc.'s SEC filings. Latest annual report filed Apr 7, 2026.

Key statistics

Fiscal 2025 from SEC filings. Methodology
Revenue (FY25)$11.5M
Revenue growth−1.5%
Revenue, 5-yr CAGR+4.2%
Gross margin67.2%
Operating margin−398.8%
Net margin−465.4%
ROICn/a
Return on equityn/a
Debt / equityn/a
Free cash flown/a
FCF marginn/a
Share count change+691.9%

Financials

Fiscal years, $M
Item20212022202320242025
Revenue412101212
Operating income−41−34−34−31−46
Net income−0−0−0−38−54
Free cash flow−35−33n/a−29n/a

Recent filings

From SEC EDGAR

Peers

Pharmaceutical preparations